Genomic Mapping of Splicing-Related Genes Identify Amplifications in <i>LSM1</i>, <i>CLNS1A,</i> and <i>ILF2</i> in Luminal Breast Cancer

by María del Mar Noblejas-López, Igor López-Cade, Jesús Fuentes-Antrás, Gonzalo Fernández-Hinojal, Ada Esteban-Sánchez, Aránzazu Manzano, José Ángel García-Sáenz, Pedro Pérez-Segura, Miguel De La Hoya, Atanasio Pandiella, Balázs Győrffy, Vanesa García-Barberán, Alberto Ocaña
Published 2021-08-01

ROLE OF MORPHOLOGICAL AND GENETIC STRUCTURAL CHARACTERISTICS OF ESTROGEN RECEPTOR ALPHA IN THE DEVELOPMENT OF RESISTANCE TO ENDOCRINOTHERAPY WITH TAMOXIFEN IN PATIENTS WITH LUMINAL...

by Е. М. Slonimskaya, S. V. Vtorushin, N. N. Babyshkina, S. V. Patalyak
Published 2016-02-01

A Case of Locally Advanced Breast Cancer Successfully Treated with Multidisciplinary Therapy

by Masafumi Tomita, Shoji Oura, Shinichiro Makimoto
Published 2020-03-01

Identification of methylation sites and signature genes with prognostic value for luminal breast cancer

by Bin Xiao, Lidan Chen, Yongli Ke, Jianfeng Hang, Ling Cao, Rong Zhang, Weiyun Zhang, Yang Liao, Yang Gao, Jianyun Chen, Li Li, Wenbo Hao, Zhaohui Sun, Linhai Li
Published 2018-04-01

Oral Selective Estrogen Receptor Degraders (SERDs) as a Novel Breast Cancer Therapy: Present and Future from a Clinical Perspective

by Cristina Hernando, Belén Ortega-Morillo, Marta Tapia, Santiago Moragón, María Teresa Martínez, Pilar Eroles, Iris Garrido-Cano, Anna Adam-Artigues, Ana Lluch, Begoña Bermejo, Juan Miguel Cejalvo
Published 2021-07-01

Effect of Chaishao Jieyu Decoction combined with Pingxiao Capsule on the patients with luminal breast cancer after operation

by Ming-Xu Hu
Published 2020-11-01

Overexpression of FAM234B Predicts Poor Prognosis in Patients with Luminal Breast Cancer

by Lyu L, Wang M, Zheng Y, Tian T, Deng Y, Xu P, Lin S, Yang S, Zhou L, Hao Q, Wu Y, Dai Z, Kang H
Published 2020-12-01

Intratumoral Heterogeneity of Expression of 16 miRNA in Luminal Cancer of the Mammary Gland

by Yuliya A. Veryaskina, Sergei E. Titov, Vlada V. Kometova, Valerii V. Rodionov, Igor F. Zhimulev
Published 2020-05-01

The prognostic significance of topoisomerase II alpha protein in early stage luminal breast cancer

by Xin An, Fei Xu, Rongzhen Luo, Qiufan Zheng, Jiabin Lu, Yanhua Yang, Tao Qin, Zhongyu Yuan, Yanxia Shi, Wenqi Jiang, Shusen Wang
Published 2018-03-01

Should a Multigene Signature be Used in all Luminal Early Breast Cancers

by Nawale Hajjaji, Nawale Hajjaji, Yves Marie Robin, Yves Marie Robin, Jacques Bonneterre, Jacques Bonneterre
Published 2019-06-01

First- and second-line treatment strategies for hormone-receptor (HR)-positive HER2-negative metastatic breast cancer: A real-world study

by Debora Basile, Lorenzo Gerratana, Carla Corvaja, Giacomo Pelizzari, Giorgia Franceschin, Elisa Bertoli, Lorenza Palmero, Diego Zara, Martina Alberti, Silvia Buriolla, Lucia Da Ros, Marta Bonotto, Mauro Mansutti, Simon Spazzapan, Marika Cinausero, Alessandro Marco Minisini, Gianpiero Fasola, Fabio Puglisi
Published 2021-06-01

FGFR1 amplification or overexpression and hormonal resistance in luminal breast cancer: rationale for a triple blockade of ER, CDK4/6, and FGFR1

by Silvana Mouron, Luis Manso, Eduardo Caleiras, Jose L. Rodriguez-Peralto, Oscar M. Rueda, Carlos Caldas, Ramon Colomer, Miguel Quintela-Fandino, Maria J. Bueno
Published 2021-02-01

Prognostic Relevance of Neutrophil to Lymphocyte Ratio (NLR) in Luminal Breast Cancer: A Retrospective Analysis in the Neoadjuvant Setting

by Antonino Grassadonia, Vincenzo Graziano, Laura Iezzi, Patrizia Vici, Maddalena Barba, Laura Pizzuti, Giuseppe Cicero, Eriseld Krasniqi, Marco Mazzotta, Daniele Marinelli, Antonella Amodio, Clara Natoli, Nicola Tinari
Published 2021-07-01

A subset of activated fibroblasts is associated with distant relapse in early luminal breast cancer

by Claire Bonneau, Antoine Eliès, Yann Kieffer, Brigitte Bourachot, Sylvain Ladoire, Floriane Pelon, Delphine Hequet, Jean-Marc Guinebretière, Christophe Blanchet, Anne Vincent-Salomon, Roman Rouzier, Fatima Mechta-Grigoriou
Published 2020-07-01

Therapeutic role of recurrent ESR1-CCDC170 gene fusions in breast cancer endocrine resistance

by Li Li, Ling Lin, Jamunarani Veeraraghavan, Yiheng Hu, Xian Wang, Sanghoon Lee, Ying Tan, Rachel Schiff, Xiao-Song Wang
Published 2020-08-01

Circulating tumor cells and palbociclib treatment in patients with ER-positive, HER2-negative advanced breast cancer: results from a translational sub-study of the TREnd trial

by Francesca Galardi, Francesca De Luca, Chiara Biagioni, Ilenia Migliaccio, Giuseppe Curigliano, Alessandro M. Minisini, Martina Bonechi, Erica Moretti, Emanuela Risi, Amelia McCartney, Matteo Benelli, Dario Romagnoli, Silvia Cappadona, Stefano Gabellini, Cristina Guarducci, Valerio Conti, Laura Biganzoli, Angelo Di Leo, Luca Malorni
Published 2021-03-01

Role of proteasome system in prognosis of breast cancer progression

by E. E. Shashova, N. A. Tarabanovskaya, L. N. Bondar
Published 2018-09-01

Breast cancer immunophenotype and its relationship with haematopoiesis

by Denis A. Ryabchikov, Svetlana V. Chulkova, Farhad A. Shamilov, Nail V. Chanturia, Sergey D. Zheltikov, Nikolai N. Tupitsyn
Published 2021-08-01

Estrogen Receptor-Alpha and p53 Status as Regulators of AMPK and mTOR in Luminal Breast Cancer

by Nishant Gandhi, Chetan C. Oturkar, Gokul M. Das
Published 2021-07-01

Studying GATA3, FOXA1, and ELF5 transcription factors in the evaluation of prognosis in luminal breast cancer patients

by S. V. Vtorushin, D. V. Vasilchenko, M. V. Zavyalova, N. V. Krakhmal’, S. V. Patalyak
Published 2021-01-01